KRISTEN PRICE: Open Payments
NPI 1033987763 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 90 payments from 16 companies in 2025. Trend: 2023 $15 · 2024 $522 · 2025 $1,414
Food & beverage: $1,414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $414 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $153 |
| Gilead Sciences, Inc. | 10 | $142 |
| Ardelyx, Inc. | 5 | $93 |
| Lilly USA, LLC | 5 | $92 |
| Celltrion USA Inc. | 4 | $82 |
| Madrigal Pharmaceuticals | 4 | $78 |
| QOL Medical, LLC | 3 | $71 |
| Aimmune Therapeutics, Inc. | 4 | $69 |
| Janssen Biotech, Inc. | 2 | $47 |
Products named: RINVOQ, ENTYVIO, IBSRELA, OMVOH, SKYRIZI, VEGZELMA, REZDIFFRA, MAVYRET.
Industry payments across GA — which companies pay providers there.
